FDA — authorised 23 November 1962
- Application: NDA013428
- Marketing authorisation holder: ENDO PHARMS
- Local brand name: VALPIN 50
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Valpin in United States
FDA authorised Valpin on 23 November 1962
Marketing authorisations
FDA — authorised 14 April 1983
- Application: ANDA086046
- Marketing authorisation holder: WATSON LABS
- Local brand name: ANISOTROPINE METHYLBROMIDE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Status: approved
Valpin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in United States
Frequently asked questions
Is Valpin approved in United States?
Yes. FDA authorised it on 23 November 1962; FDA authorised it on 14 April 1983; FDA has authorised it.
Who is the marketing authorisation holder for Valpin in United States?
ENDO PHARMS holds the US marketing authorisation.